Skip to main content
Article
Usefulness of Hemoglobin A1c to Predict Outcome After Cardiac Resynchronization Therapy in Patients With Diabetes Mellitus and Heart Failure
American Journal of Cardiology (2012)
  • Ravi V. Shah, Harvard University
  • Robert K. Altman, Harvard University
  • Mi Young Park, Harvard University
  • Jodi Zilinski, Harvard University
  • Jordan Leyton-Mange, Harvard University
  • Mary Orencole, Harvard University
  • Michael H. Picard, Harvard University
  • Conor D. Barrett, Harvard University
  • E. Kevin Heist, Harvard University
  • Gaurav Upadhyay, Harvard University
  • Ranendra Das, Johns Hopkins University
  • Jagmeet P. Singh, Harvard University
  • Saumya Das, Beth Israel Deaconess Medical Center
Publication Date
September 1, 2012
DOI
10.1016/j.amjcard.2012.04.056
Citation Information
Ravi V. Shah, Robert K. Altman, Mi Young Park, Jodi Zilinski, et al.. "Usefulness of Hemoglobin A1c to Predict Outcome After Cardiac Resynchronization Therapy in Patients With Diabetes Mellitus and Heart Failure" American Journal of Cardiology Vol. 110 Iss. 5 (2012) p. 683 - 688
Available at: http://works.bepress.com/jodi-zilinski/2/